Skip to the page

Data / Form D filings / VELIUS, LLC

VELIUS, LLC: Form D filing

VELIUS, LLC, a pharmaceuticals company in Great Neck, NY, filed a Form D with the SEC in 2014. The latest, on May 16, 2014, reports an offering of $7 million with nothing sold yet.

Find out what VELIUS, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
15 BARSTOW ROAD, Great Neck, NY, 11021
Phone
(516) 482-8050
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1608403

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 16, 2014New notice$7,000,000$0$7,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joel Roy StudinExecutive Officer, Director
Peter Yarnton MillsExecutive Officer
James Edward DunnExecutive Officer
Thomas Joseph JenningsDirector
William Alan LandmanDirector
Andrew Bart OxenhornDirector
Lester Bart RosenkrantzDirector

Other pharmaceuticals companies in New York that filed recently

Every Form D from the week of May 12, 2014 · All recent filings in New York · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what VELIUS, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.